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Abstract Over the last few years, the number of people
living with HIV who have been convicted for not disclosing
their HIV status to sexual partners in Canada has been
steadily increasing. Whilst these laws are criminal in nature,
and not public health-based, it is important to examine their
effect on public health HIV prevention efforts. To under-
take such an analysis, the impact fraction model was used
to structure and examine the extant literature about HIV
transmission, HIV status awareness and HIV testing
practices. The findings of this analysis indicate that
although these laws might prevent HIV transmission in a
few isolated cases, it is unlikely that they would influence
overall population-level rates of HIV transmission. Some
evidence even suggests that these laws could exacerbate
HIV transmission.
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Introduction
Whilst the last few years have witnessed many changes in
the health care practices that relate to HIV management,
care and quality-of-life outcomes for people living with
HIV and AIDS (PHA), in Canada, significant alterations
have also occurred regarding the legal context surrounding
the disclosure of a person’s HIV-positive serological status
(henceforth referred to as serostatus disclosure). This
change, specifically in the Canadian context, has included
an increase in the frequency of charges being brought
against PHAs; by the end of 2009, there had been 96
prosecutions related to serostatus non-disclosure across
Canada, with >70 of these cases having resulted in
conviction, and more than 35 having been between 2006
and 2009 (Myhkalovskiy et al. 2010). In reaction to this
increasing practice of criminally charging PHAs for not
disclosing their serostatus, many advocacy/legal groups that
work with and for PHAs have denounced this trend (see
Cameron 2009; Symington 2009). Some researchers,
moreover, have begun to examine PHA’s degree of
awareness about HIV criminal law and the effects that this
law might have on behaviour (Adam et al. 2008; Burris et
al. 2007; Galletly and Pinkerton 2006, 2008; Lazzarini et al.
2002). These findings are presented below.
Notwithstanding this research base what continues to be
underrepresented in the current debates is empirically
informed discussions/examinations of the criminal prosecu-
tion of serostatus non-disclosure from a public health
perspective. Indeed, the research literature to date focuses
more on ethical and legal issues than public health, which is
surprising and disconcerting because, first, HIV is a public
health issue and, second, the current legal context in Canada
may unwittingly undermine HIV prevention efforts across the
country; other countries may be experiencing similar legal
trends, but have not yet been examined either. To address this
gap, this paper summarizes the extant literature about HIV
transmission and disclosure law (the latter item specifically in
the Canadian context) and then structures this work from a
public health/HIV prevention perspective using the impact
fraction model. The questions posed as part of this examina-
tion are thus, to what extent and effect do serostatus disclosure
laws, which have a criminal and not public health focus,
function as HIV prevention initiatives? Do criminal laws that
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relate to serostatus non-disclosure affect public health efforts,
and if so, in what way? To date, no discussions have
specifically addressed questions relating to the relationship
between the criminalization of serostatus non-disclosure and
public health.
Conceptual Framework: The Impact Fraction Model
To undertake this analysis, the impact fraction model was
be used. As its name indicates, this model highlights that
the impact of a health intervention depends on (1) the
fractional importance of a target group (i.e. how much does
the target population contribute to the overall health status
of a population?); (2) the efficacy of the proposed
intervention (i.e. how well does it work?); and (3) the
coverage that can be achieved when a specific intervention
is implemented (i.e. how many individuals actually use or
are involved in the intervention?; Dooley and Thrun 2008;
Aral et al. 2007). According to the impact fraction model,
whilst each of the foregoing items affects an intervention’s
impact, it is the combination of these factors that ultimately
determines an intervention’s overall effect on health. As a
formula:
Impact½  ¼ Importance of Group½   Intervention Efficacy½ 
 Intervention Coverage½ 
As this relates to HIV, the most profound prevention
effects would therefore occur if highly efficacious inter-
ventions were implemented with high uptake among
individuals who are most responsible for transmission. In
this context, to determine whether the criminal enforcement
of serostatus disclosure would have a profound public
health/prevention impact, the literature on HIV transmis-
sion and disclosure law will be examined using the impact
fraction model.
Background Information: HIV Transmission and HIV
Criminal Law
HIV Transmission in Canada
In Canada, the overall incidence of HIV has remained
relatively stable since 2001: approximately 2,300 to 4,300
new cases occurring annually, with roughly 80% (1,840–
3,440) of these cases occurring by means of sexual contact.
Although this figure has not fluctuated greatly since 2001,
the absolute number of PHAs has continued to grow during
this time. At present, there are approximately 65,000 (range
of 54,000–76,000) PHAs in Canada, which equates to a
prevalence of 0.4% (PHAC 2009). Compounding this
situation is that PHAC estimates only 74% (48,100; range,
39,960–56,240) of PHAs in Canada are aware of their
serostatus; the remaining 26% (16,900; range, 14,040–
19,760) do not know that they are living with HIV (PHAC
2009). Of particular importance, research by Marks et al.
(2005) highlights that this latter group might be responsible
for 54–70% of all new cases of HIV.
By the numbers, this means that in Canada, 26%
(16,900; range, 14,040–19,760) of the entire prevalent
group (65,000; range, 54,000–76,000) cause between 994–
1,288 (54–70%, respectively, of the lower number of 1,840
incident cases) and 1,858–2,408 (54–70%, respectively, of
the higher number of 3,440 incident cases) of the annual
incident cases of HIV in Canada each year (PHAC 2009).
As rates, one can suggest an HIV transmission rate (by
means of sexual contact) that ranges between 5.88–7.62%
(944–1,288 cases divided by 16,900, the 26% of PHAs
unaware of serostatus) and 10.99–14.25% (1,858–2,408
cases divided by 16,900, the 26% of PHAs unaware of
serostatus). When these figures are generated for the 74%
(48,100; range, 39,960–56,240) of PHAs aware of their
serostatus, a markedly different set of rates emerges: HIV
transmission among PHAs aware of their serostatus ranges
between 1.15–1.76% (552–847 divided by 48,100) and
2.15–3.29% (1,032–1,583 divided by 48,100). These
numbers thus reveal that there are significantly higher rates
of HIV transmission among people who are unaware of
their serostatus than among individuals who are aware that
they are living with HIV. See Table 1 for a summary of
these figures.
Individuals who are unaware of their serostatus are
not, however, a homogenous group. There is a distinction
between individuals who have an acute infection (who,
in many situations, cannot be diagnosed with HIV) and
individuals who do not undergo HIV testing. Research
on the role of acute HIV infection in the sexual
transmission of HIV indicates that the heightened
concentration of HIV in genital fluids during this time
period may be relatively small or quite significant;
mathematical modelling predicts that anywhere between
1% and 82% of new HIV infections are the result of a
sexual partner who is in the acute period of HIV
infection. The variability of these numbers relates to an
array of factors: the stage of the HIV epidemic (i.e. Is
HIV a new or established infection within a given
population?); the time between HIV acquisition and
diagnosis (i.e. What is the proportion of delayed HIV
diagnoses?); the sexual dynamics of specific groups (e.g.
What are the rates of sexual concurrency and new
partnerships?); and the rates of HIV testing among
members of a specific population of interest (i.e. How
many people in a group are unaware of their serostatus/
how frequently do individuals undergo HIV testing?).
Sex Res Soc Policy (2012) 9:70–79 71
As noted above, in the Canadian context, the proportion of
individuals unaware of their serostatus is estimated to be 26%
(Marks et al. 2005). The percentage of this group that is
within the acute HIV infection period, however, is likely
small: Research identifies that in Canada, upwards of 62% of
HIV diagnoses are delayed, meaning that nearly two thirds of
people in Canada receive their initial HIV diagnosis within
12 months of being diagnosed with AIDS (Hall et al. 2009).
Consequently, in the absence of any research data that
precisely focus on the role of acute HIV infection in HIV
transmission in Canada, it appears as though the available and
related information which exists suggests that whilst acute
HIV infection may correspond with an increased degree of
HIV transmissibility, the significance of this stage of infection
cannot be overstated in the Canadian context because of the
large number of people who receive delayed HIV diagnoses.
In other words, acute HIV infection likely plays a role, but the
available research suggests that this role is likely small.
HIV Criminal Law
In Canada, there are no formally enacted statutes which
criminalize any aspect of HIV transmission or serostatus
disclosure. There are, however, legal precedents, the most
notable of which is the Supreme Court of Canada’s R. v.
Cuerrier case from 1998, in which a man who transmitted
HIV during unprotected vaginal sex was convicted of
aggravated assault. In this ruling, the Supreme Court
established that people living with HIV must disclose their
serostatus prior to the onset of any sexual contact that poses a
“significant risk” for HIV transmission, provided that the
awareness of this information would have changed whether or
not sexual contact would have occurred (CHALN 2004). The
court insisted that failure to disclose one’s serostatus invalid-
ates consent, if and when the disclosure of this information
would have impacted on a person’s decision to give consent.
As part of this, the court also ruled that HIV transmission is an
act that inflicts irreversible harm onto another person. This
ruling thus established that the issue under Canadian law is
one of serostatus disclosure, not HIV transmission or intent to
transmit HIV (CHALN 2004). It is worth noting that this
ruling established a legal precedent that contrasts with the
HIV criminalization policy issued by the Joint United Nations
Programme on HIV/AIDS (UNAIDS), which focuses on HIV
transmission and mental culpability (e.g. intent).
Further complicating the Canadian ruling, however, is
that the Supreme Court failed to establish a clear threshold
or test for “significant risk” in the Cuerrier case. Conse-
quently, the lower Canadian courts have been forced to
interpret the meaning of this phrase (Symington 2009).
They have done so inconsistently (and inaccurately in
relation to the extant scientific data on HIV transmission),
both acquitting and convicting people for protected vaginal
sex and for unprotected oral sex. Non-uniform rulings have
Table 1 HIV transmission in Canada
Item Numbers
Prevalence 65,000 (54,000–76,000)
Serostatus awareness 26% unaware 74% aware
16,900 (14,040–19,760) 48,100 (39,960–56,240)
Incidence 2,300–4,300
80% related to sexual transmission=1,840–3,440 cases
Incidence and serostatus
awareness
26% unaware of serostatus involved in 54-70%
of sexually transmitted HIV
74% aware of serostatus involved in 30-46%
of sexually transmitted HIV
1,840 3,440 1,840 3,440
54% 994 1,858 30% 552 1,032









¼ 5:88 7:62%ð Þ to 10:99 14:25%ð Þ ¼ 1:15 1:76%ð Þ to 2:15 3:29%ð Þ
Therefore, the rate of sexually transmitted HIV for people
unaware of serostatus is between 5.88% and 14.25%
Therefore, the rate of sexually transmitted HIV for people









¼ 38:23 49:54ð Þ to 71:46 92:62ð Þ ¼ 7:46 11:45ð Þ to 13:95 21:39ð Þ
Therefore, there are between 38 and 93 incident cases
of HIV per 1% of people unaware of serostatus
Therefore, there are between 7 and 21 incident cases
of HIV per 1% of people aware of serostatus
a The average figure was used here intentionally to avoid producing additional ranges
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also arisen within the lower courts in relation to the
significance, meaning and interpretation of a person’s viral
load and its potential impact on HIV transmission. In some
cases, an undetectable viral load was accepted as a valid
defence, whilst in another case, a PHA’s reliance on his
undetectable viral load was interpreted by the judge as an
attempt by the accused to shirk his disclosure responsibility;
the judge in the latter case considered the PHA’s use of
information about viral load an exacerbating factor that
resulted in maximal sentencing (JQ no 367 2011). In its
totality, the result of the foregoing legal scenario in Canada
regarding serostatus disclosure is a general state of confusion
among lawyers, health care professionals, and PHAs about the
types of sexual practices (e.g. anal, oral, vaginal) and the
pertinent parameters (e.g. viral load, use of condoms or other
protective devices) that determine whether or not serostatus
disclosure is required (Symington 2009; Adam et al. 2008).
Lastly, to completely understand the Canadian context, a
second case must also be addressed, the R. v. Williams case,
in which the Supreme Court of Canada established that
serostatus disclosure is required, not only after a positive
HIV diagnosis, but also when a person has a strong
suspicion that he/she could be living with HIV. Conse-
quently, being named as a contact of HIV likely requires
disclosure that one may be HIV-positive. Again, however,
the Supreme Court of Canada failed to clearly articulate its
rulings: They did not identify the precise degree of
suspicion (the threshold of suspicion, that is) which
warrants serostatus disclosure. Moreover, further ambiguity
arises in this scenario because no cases have gone before
any lower courts to test/refine this legal precedent; even
Williams had been definitively diagnosed with HIV by the
time that he was charged by the police with failing to
disclosure his serostatus in situations that pose a so-called
significant risk for HIV transmission.
Using the Impact Fraction Model
At this point, the literature about HIV transmission and
Canadian criminal law that relates to serostatus non-
disclosure will be examined using the impact fraction model.
This will occur by filtering the extant literature into the
model’s three sections: (1) significance of target population;
(2) efficacy of intervention; and (3) coverage of intervention.
Significance of Target Population
In determining the significance of a target population, one
must identify, first, the target group of a specific interven-
tion and, second, the contribution of this target group to the
overall (i.e. population level) impact and scope of a specific
health issue of concern. In this context, the item of interest
is criminal laws which focus on HIV serostatus non-
disclosure and the outcome is HIV prevention. The goal
in this context is therefore to determine what public health
HIV prevention effect these criminal laws might induce
based on the group that these laws target. Pursuant to
Canadian legal precedents, the target group comprises
PHAs who are cognizant/suspicious of their serostatus.
Because it is serostatus disclosure and not HIV transmis-
sion that is the issue under Canadian law, a person can only
be charged for and convicted of not disclosing his/her
serostatus if he/she has been diagnosed with HIV (as per
the Cuerrier ruling); alternatively, these laws apply when a
person is aware that he/she might be HIV-positive, e.g. is
named as a contact of HIVor has regular sexual contact with a
person living with HIV (as per the Williams ruling). Accord-
ingly, based on the Supreme Court’s R. v. Cuerrier and R. v.
Williams rulings, the group in Canada that is targeted by
criminal legal precedents which focus on serostatus non-
disclosure comprises PHAs who are aware of their serostatus
and individuals who are likely to be HIV-positive. Everyone
else is exempt from these criminal liabilities.
Regarding the significance of the target population, the
aforementioned data about HIV transmission in the Cana-
dian context (summarized in Table 1) indicates that existing
HIV disclosure laws are likely to induce small HIV
prevention outcomes because they only apply to the group
of PHAs who contribute 30% to 46% of the annual HIV
incidence in Canada, which is somewhere between 552
(30% of 1,840) and 1,583 (46% of 3,440) of the 1,840–
3,440 incident cases of HIV that occur by means of sexual
contact each year (PHAC 2009). In other words, these laws
focus on the large group of PHAs who are aware of their
serostatus (74% of the prevalence, totalling 48,100 people;
range, 39,960–56,240 individuals) and who have an HIV
transmission rate that ranges between the conservative
estimate of 1.15% and the liberal estimate of 3.29%. These
laws have no effect, by comparison, on the significantly
smaller group of PHAs who are unaware of their serostatus
(26% of HIV prevalence, totalling 16,900 people; range,
14,040–19,760 individuals) and who have an estimated
HIV transmission rate that varies between a low-end
estimate of 5.88% (when 16,900 individuals are involved
in 994 cases, or 54%, of HIV transmission) and a high-end
estimate of 14.25% (when 16,900 individuals are involved
in 2,408 cases, or 70%, of HIV transmission). To illustrate
this point further, there are 38–93 incident cases of HIV per
1% of people unaware of their serostatus, in contrast to the
7–21 incident cases of HIV per 1% of people aware of their
serostatus. Thus, despite the group that is targeted by
Canadian serostatus non-disclosure criminal precedents
constituting 74% of the prevalent HIV population (which
equals 48,100 people; range, 39,960–56,240), the potential
prevention impact of these laws is likely small.
Sex Res Soc Policy (2012) 9:70–79 73
This conclusion does not signify, however, that HIV
prevention interventions which focus on groups that are
involved in a small number of HIV transmission cases are
neither effective nor important. Rather, the assertion here
simply follows from the impact fraction model that greater
population-level reductions in HIV transmission would like
occur if HIV prevention efforts were more precisely
focused on the smaller groups of people who are unaware
of their positive serostatus and who are disproportionately
involved in the majority of cases of HIV transmission. Such
an approach would likely emphasize an increase in HIV
testing among specific subpopulations who are dispropor-
tionately burdened by HIV, such as men who have sex with
men, aboriginals, prison inmates and individuals of African/
Caribbean ancestry. Such an approach might help decrease
delayed HIV diagnosis and may identify individuals who
are in the acute HIV infection period within the groups that
(1) are most profoundly affected by HIV and (2) which
most profoundly affect the overall population rates of HIV
incidence and prevalence.
Efficacy of Intervention
Because the Canadian courts have ruled that PHAs must
disclose their serostatus prior to engaging in sexual
activities that pose a “significant risk” for HIV transmis-
sion, provided that such disclosure would affect consent, it
is important to review the literature that examines the
relationship between HIV disclosure, the criminal law and
HIV transmission. Ultimately, the impact fraction model
highlights the need to determine whether an intervention,
(criminal legal precedents about serostatus disclosure in this
case), actually produces any HIV prevention outcomes.
That is, do these laws actually induce serostatus disclosure,
and do these laws change the likelihood of HIV transmis-
sion? A yes for either/both of these questions would signal
that these laws could help reduce overall rates of HIV
transmission; a no, by comparison, would indicate that
these laws likely have little, no, or even a negative impact
on HIV prevention.
As with the previous category, there is again no currently
available research which specifically examines whether HIV-
related criminal laws actually promote, induce, or enhance
serostatus disclosure. This is troublesome because an array of
research demonstrates that many factors influence, and make
it difficult to undertake, serostatus disclosure in real life, e.g.
threats or experiences of violence, rejection, stigmatization,
and discrimination by friends, family, peers, the general
public, and health care professionals (Niccolai et al. 1999).
Notwithstanding this paucity of evidence, there is one study
wherein researchers examined the relationships between HIV
criminal laws and people’s sexual practices (Burris et al.
2007). This research involved 490 individuals (162 of which
were people knowingly living with HIV) and occurred in
Chicago (n=248) and New York City (n=242). As its
outcomes, the data showed no relationships between (1) laws
which proscribe certain sexual practices or require serostatus
disclosure and (2) people’s safer sex practices— this was the
case regardless of the participant’s serostatus (Burris et al.
2007). One interesting finding, nevertheless, was that the
Chicago-based participants reported higher rates of unpro-
tected sexual contact after serostatus disclosure. (More
research is needed to explore this finding.) As part of this
study, Burris et al. (2007) also examined whether HIV-
related criminal laws affect social norms; they questioned
whether these laws change the participants’ perceptions/
beliefs about serostatus disclosure? The answer that was put
forward by Burris et al. (2007) was, again, that these laws
have no effect. Most of the participants believed that
serostatus disclosure was “morally right” and that it should
occur regardless of legal obligations (Burris et al. 2007).
Moral conviction about serostatus disclosure, unlike the
criminal law, consistently predicted serostatus disclosure
(Burris et al. 2007).
Another study by Horvath et al. (2010) validated the
findings of Burris et al. (2007). In a study of 1,725 men
who have sex with men over a 3.5-month period in multiple
states (with and without HIV-related criminal laws),
Horvath et al. (2010) found that HIV-specific criminal laws
or statutes which focus on transmission and/or serostatus
disclosure have no effect on the occurrence of unprotected
anal intercourse. Horvath et al. (2010) thus concluded, in
the same way as Burris et al. (2007), that HIV-related laws
“are not a deterrent to sexual risk taking among MSM [men
who have sex with men]” (p. 1226). The benefit of this
second study is that it replicated and validated Burris et
al.'s findings (2007), consequently mounting evidence
about how inefficacious HIV-related criminal laws and
statutes are as HIV prevention/public health initiatives.
A second component of determining whether criminal
laws which require serostatus disclosure actually decrease
the likelihood of HIV transmission is to establish the
relationship between serostatus disclosure and HIV trans-
mission. For serostatus disclosure to function as an HIV
prevention strategy, it would have to induce safer sex and
consequently decrease HIV transmission. Whilst the crim-
inal law in Canada may focus on issues of consent, in this
context, its relationship to and affect on HIV prevention is
the point of interest and examination.
The literature on this topic (about serostatus disclosure
and sexual practices, that is) produces mixed results,
however. According to a recent review article, it is
impossible to discern whether serostatus disclosure actually
has any effect on safer sex practices and HIV transmission
(Simoni and Pantalone 2004). Although some researchers
found that serostatus disclosure corresponds with decreased
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HIV transmission, others found that it had absolutely no
effect; other researchers, meanwhile, identified that the
relationship between these two items depended on extenu-
ating circumstances, signalling that serostatus disclosure
does not consistently correspond with changes in sexual
behaviour that limit HIV transmission (Simoni and
Pantalone 2004). This means that whilst disclosure can
affect sexual behaviour for some people in certain circum-
stances, many individuals who are HIV-negative knowingly
engage in unprotected sex with people living with HIV. One
item of importance when reviewing this material, however,
is that some of these studies failed to differentiate between
practices that are likely/unlikely to transmit HIV (e.g. oral
vs. protected vaginal/anal vs. unprotected vaginal/anal sex).
It could be, quite simply, that sexual contacts still occurred
in many cases, but in ways that prevent HIV transmission.
To explain these studies, first, among their 255
multiethnic men living with HIV in Los Angeles, De
Rosa and Marks (1998) found that protected sexual
contact occurred more commonly after serostatus dis-
closure. Similarly, among 609 men of various ethnicities
living with HIV in Los Angeles, Marks et al. (1994) found
people living with HIV a slight increase in the frequency
of unprotected insertive anal sex after serostatus disclosure
than when serostatus disclosure did not occur, 18% and
23% respectively. Sturdevant et al. (2001) produced
corresponding results with a group of 153 sexually active
adolescent girls living with HIV, wherein less condom use
was reported when serostatus disclosure did not occur. In
contrast, however, Crepaz and Marks (2003) identified
that there was no identifiable relationship between
serostatus disclosure and safer sex in their research sample
of 105 men who are living with HIV in Los Angeles.
Marks and Crepaz (2001) had previously found similar
results: Among 206 men of various ethnicities living with
HIV in Los Angeles, the occurrence of unsafe sex was
identical regardless of whether serostatus disclosure occurred
or not. Likewise, among 269 men and women who are living
with HIV, Kalichman et al. (2002) found that regardless of
serostatus disclosure, protected sex occurred at the same
frequency with both regular and non-regular partners.
D’Angelo et al. (2001) had previously produced the same
results with 203 male and female adolescents living with
HIV. Ultimately, these results highlight that serostatus
disclosure should not be considered an efficacious HIV
prevention strategy.
Coverage of Intervention
The third aspect of the impact fraction model focuses on
coverage, which relates to the number of people within a
specific group of interest (i.e. the target population) whom
an intervention addresses and the proportion of these
individuals for whom the intervention can be or is
actualized in a way that promotes desired outcomes (e.g.
health promotion or illness prevention). Coverage, as it is
used in this context, therefore describes the extent of an
intervention’s applicability, uptake, or use by the members
of a specific community, not its uptake, use, or application
within the general population. Herein, examinations of
coverage query how many PHAs who know their serostatus
are aware of their local HIV-related criminal laws which
mandate serostatus disclosure.
To answer this question, a few sources of information
can be drawn from. The first is an empirical study by
Galletly et al. (2009) which sought to determine the
proportion of diagnosed PHAs who were aware of their
jurisdictional serostatus disclosure laws in one unidentified
US state. This study involved 384 PHAs, of which 63.9%
were male, 54.3% black and 54.3% men who had sex with
both men and women. The findings of this study revealed
that most participants (76%) were aware of relevant laws,
but that 19.3% of the study sample were nevertheless
unaware whether serostatus disclosure laws existed, and
4.7% believed that no such laws existed in their state.
Based on these findings, Galletly et al. (2009) concluded
that comprehension of these laws was “generally good”
within their study sample and that this was likely due to
diagnosed PHAs receiving information about these laws
from a variety of sources: HIV support groups, AIDS
service organizations, health care professionals, public
health departments, general media, and so forth (p. 1265).
As indicated by this study, coverage, if measured in relation
to knowledge about HIV disclosure laws, appears to be
high.
A qualitative study by Adam et al. (2008), meanwhile,
explored in greater detail the interpretation and meaning of
serostatus disclosure laws for 34 men living with HIV in
Canada (Toronto, Ontario, specifically). The results of this
study identified “ambiguity and uncertainty” among the
participants regarding the meaning and significance of
Canadian serostatus disclosure laws in real-life (p. 159).
Thus, whilst the participants appeared to be generally aware
of the R. v. Cuerrier precedent, they were neither in
agreement about whether it was beneficial nor were they
clearly able to surmount some of the “practical dilemmas”
which are associated with this criminal law (p.160). This
second study, when considered in hand with the findings of
Galletly et al. (2009), suggests that although survey-based
data collection about serostatus disclosure laws reveal a
high degree of awareness, in-depth qualitative-based dis-
cussions highlight many shortcomings in PHAs' actual
understandings of these laws, e.g. what they mean in and as
part of real life, day-to-day sexual interactions and person-
to-person communication. Nevertheless, both studies did
demonstrate a relatively high degree of coverage: Most
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participants were aware of local laws which mandate
serostatus disclosure in particular situations.
Discussion
When the Canadian criminal legal precedents that require
serostatus disclosure (R. v. Cuerrier and R. v. Williams) are
examined using the impact fraction model, it appears as
though the public health and HIV prevention effects of
these rulings would likely be limited. Indeed, whilst
enforcement of serostatus disclosure by means of criminal
law might affect transmission in a small number of cases
(although Cameron 2009 argues that such an assertion is
debatable), the overall population-level HIV prevention
impact of these laws would probably be quite limited. This
is particularly the case when these HIV prevention effects
are compared with the prevention impact that could arise if
interventions were focused in other subpopulations, such as
among the individuals in sexual networks with high HIV
incidence and prevalence who are unaware of being HIV-
positive. This conclusion is well founded because, regard-
ing the impact fraction model, Canadian serostatus disclo-
sure laws have two shortcomings that limit their success.
First, extant serostatus non-disclosure law focuses on the
people living with HIV who are likely involved in the
minority of HIV transmission in Canada; PHAs who are
aware of their serostatus are likely involved in 30% to 46%
of new cases of HIV. In contrast, PHAs who are unaware of
their serostatus are likely involved in 54% to 70% of on-
going HIV transmission. As this relates to HIV prevention,
it is distinctly possible that a more profound HIV
prevention effect could arise if the smaller group of PHAs
who are unaware of their serostatus, but who are involved
in the majority of HIV transmission, were identified as the
priority group for HIV prevention. (As noted above, within
the Canadian context, this would mean that HIV prevention
efforts should focus on men who have sex with men,
aboriginal groups, prison inmates and individuals of
African/Caribbean ancestry, to name a few groups of
importance.) As the second main shortcoming, the potential
prevention effects of Canadian criminal precedents about
serostatus disclosure are likely limited because the available
evidence refutes the idea that these rulings induce behav-
iours that decrease HIV transmission; this is the case
regarding both the relationships between these rulings and
serostatus disclosure and the correlation between serostatus
disclosure and safer sex practices. Using the language of
the impact fraction model, serostatus disclosure thus
appears to be an inefficacious HIV prevention strategy.
Compounding the fact that serostatus non-disclosure
criminal law likely has a small HIV prevention effect is that
other authors suggest that these legal precedents might
consequently decrease HIV testing among PHAs who are
unaware of their serostatus (Cameron 2009; Symington
2009; UNAIDS 2002; Galletly and Pinkerton 2006;
Bennett et al. 2000; Lazzarini et al. 2002; Wolf and Vezina
2004). Because this group of PHAs is disproportionately
implicated in continued HIV transmission, and because the
impact fraction model suggests that the proportional
significance of this group makes it is a priority population
for HIV prevention, a reduction in HIV testing, serostatus
awareness and the HIV prevention outcomes that often
correspond with serostatus awareness (e.g. viral load
suppression, behaviour change, partner notification and
follow-up by public health departments) could in fact
exacerbate population-level rates of HIV transmission. That
is, HIV transmission could worsen if people purposively
chose to decrease their criminal liability and remain
unaware of their serostatus. The logic behind this argument
is simple: Laws which target PHAs who are aware of their
serostatus may deter PHAs who are unaware of their
serostatus from wanting to undergo HIV testing. As it
stands in Canada, a person can only be charged with a
serostatus non-disclosure if he/she knows or is strongly
suspicious about his/her serostatus (whether this knowledge
arises from a definite test or from being named as a contact
of HIV by a health professional). Ignorance of one’s
serostatus (including ignorance of the possibility that one
could be HIV-positive) is therefore a form of immunity to
the Cuerrier and Williams precedents.
This incentive to be and to remain unaware of one’s
serostatus, however, conflicts with research findings which
indicate that knowing one’s serostatus corresponds with
decreased HIV transmission. This outcome also conflicts with
HIV prevention messaging issued by the World Health
Organization (WHO 2007), the Public Health Agency of
Canada PHAC (2006) and CDC (2009)—all three of whom
have highlighted the importance of removing any/all barriers
that inhibit HIV testing. In the USA, specifically, the CDC
(2009) has even gone so far as to endorse the idea of opt-out
testing (wherein an HIV test is the norm unless otherwise
stated by the patient) in an effort to minimize the number of
people who are unaware of their serostatus. However, if
individuals wish to protect themselves from serostatus non-
disclosure legal precedents, and if they refrain from access-
ing HIV testing consequently, then the already limited HIV
prevention effect of the serostatus non-disclosure rulings
would be further diminished. To explain this scenario further:
If the number of individuals who are unaware of being HIV-
positive were to increase as a consequence of these criminal
prosecutions, then the outcome could be a situation of
increased HIV transmission as a result of a larger number of
people being unaware of their serostatus.
Ironically, however, no researchers have examined
whether HIV criminal laws actually affect the uptake and
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use of HIV testing services by different subpopulations of
interest. Consequently, the only data that can inform
discussions on this topic arise from other research studies
which examine the array of factors that deter individuals
from accessing HIV testing services (see, for example,
Malta et al. 2007; Hogben et al. 2004; Maher et al. 2000).
Based on the foregoing list of research studies, which
identifies limitations of confidentiality, social stigmatiza-
tion/discrimination and fears of violence as the most
common non-monetary items that dissuade people from
undergoing HIV testing, it is not an unreasonable to
postulate that the criminal prosecution of serostatus non-
disclosure might also deter HIV testing. Public prosecutions
and the ensuring media coverage of these trials efface
confidentiality, whilst such criminal proceedings also likely
exacerbate HIV stigmatization and discrimination. Within
the present state of affairs, however, one can only speculate
that the criminal law system might deter testing because
there are no empirical studies which substantiate these
conclusions. This lack of evidence however, does not mean
that such assertions are not true; rather, it signals a need for
in-depth research on this topic.
Moving beyond the potential HIV prevention impact of
serostatus non-disclosure criminal laws, another problem
with contemporary Canadian laws is that they do not
encourage what Marks and Crepaz (2001) call “uninformed
protection”, which involves PHAs who are aware of their
serostatus (1) intentionally engaging in safer sex practices
in an effort to minimize HIV transmission (e.g. when a
person living with HIV eschews unprotected vaginal and/or
anal sex in favour of exclusive oral sexual contact) (2) but
doing so without disclosing their serostatus. Because the
current Canadian legal precedents address serostatus dis-
closure, they focus on serostatus awareness not decreasing
HIV transmission. The outcome is that, as per the R. v.
Cuerrier and R. v. Williams ruling, the Canadian criminal
system equally punishes PHAs who take all precautions to,
and successfully prevent HIV transmission, and other PHAs
who intentionally wish to and effectively do transmit HIV
to other people. It is quite plausible, therefore, that this
legal situation does not encourage PHAs who refrain from
disclosing their serostatus for whatever reasons to attempt
to minimize HIV transmission in situations wherein
serostatus disclosure did not/does not occur. Indeed,
without disclosure, the criminal act has already been
committed.
As a final point, it is important to note that the criminal law
system is not inherently opposed to HIV prevention. Rather, it
is simply that at a broad level, the criminalization of serostatus
non-disclosure might not create a social context that facilitates
safer sex, serostatus awareness and HIV prevention efforts.
When, for example, a PHA who is aware of his/her status is
forced to chose between the possibility of future criminal
proceedings and the immediate potential for violence or
rejection or humiliation, one is forced to question not just the
magnitude of the HIV prevention impact that such criminal law
could induce but also whether or not the criminal law system
actually has any potential to prevent HIV transmission.
Moreover, when the WHO, the Centers for Disease Control
and Prevention (CDC) and the Public Health Agency of
Canada (PHAC) endorse the idea of increased serostatus
awareness by means of increased HIV testing, one must
wonder whether an acceleration in criminal prosecutions for
serostatus non-disclosure, as is occurring in Canada, actually
supports a society of serostatus awareness and disclosure, of
decreased HIV-related stigmatization and discrimination and of
HIV prevention. The point here is that whilst the criminal law
punishes individuals who have engaged in proscribed actions,
it does not appear to function synergistically within the social
reality and public/public health policy environment that
surrounds HIV transmission, HIV prevention and serostatus
disclosure. Indeed, it appears as though the criminal law system
offers little promise to do anything other than exacerbate HIV
transmission within the Canadian context.
Conclusion
Reflections on the topic of HIV serostatus non-disclosure
and the criminal law that are guided by the impact fraction
model emphasize that even if these laws were to prevent
HIV transmission (which appears to be unlikely), the
potential public health prevention impact of HIV disclosure
laws is not optimal because more substantial prevention
outcomes could occur if strategic public health policy
efforts were directed toward decreasing transmission within
the smaller but more fractionally important population of
PHAs who are unaware of their serostatus. Following the
impact fraction model, which indicates that interventions
likely have a greater effect when they target smaller groups
of individuals who are disproportionately responsible for a
health issue, HIV disclosure laws do not target the group
that is most significant from a transmission and prevention
perspective. The criminal enforcement of serostatus disclo-
sure thus does not appear to be an ideal prevention strategy
because it would not likely induce much of an overall
population-level HIV prevention effect. Furthermore, this
approach also holds the potential to induce other unwanted
consequences that might impede HIV prevention, such as the
encouragement of serostatus ignorance, the exacerbation of
HIV-related stigmatization and discrimination and/or the
reduction of safer sex in situations of serostatus non-disclosure.
Consequently, when selecting between various policy
options regarding HIV prevention, it is suggested as a result
of this analysis that resources which might be devoted to the
criminal law system for HIV serostatus non-disclosure
Sex Res Soc Policy (2012) 9:70–79 77
prosecutions could be better invested elsewhere. As per the
stipulations and insights of the impact fraction model, HIV
prevention efforts should focus on the groups which are
disproportionately burdened by HIV, which account for the
largest number of people who are unaware that they are living
with HIV and which have the highest rates of HIV transmis-
sion; it is within these groups that the greatest improvements in
public health will occur. Accordingly, HIV prevention workers,
and anyone else who is also involved in making decisions that
could impact on HIV prevention for that matter, should be
cognizant that applying the harsh hand of the criminal law to a
subset of individuals who are already burdened by HIVand its
associated physical, social and inter/intrapersonal consequen-
ces could likely both (1) produce insignificant HIV prevention
outcomes and (2) induce secondary outcomes that might
exacerbate HIV transmission at the population level.
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